Hansa Biopharma AB
SWB:24H
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hansa Biopharma AB
SWB:24H
|
SE |
|
Nanofilm Technologies International Ltd
OTC:NNFTF
|
SG |
|
L
|
Lynas Rare Earths Ltd
DUS:LYI
|
AU |
|
F
|
Fortress Transportation and Infrastructure Investors LLC
NASDAQ:FTAI
|
US |
|
K
|
Kerry Group PLC
F:KRZ
|
IE |
Wall St Price Targets
24H Price Targets Summary
Hansa Biopharma AB
According to Wall Street analysts, the average 1-year price target for 24H is 5.688 EUR with a low forecast of 2.769 EUR and a high forecast of 8.237 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 24H's stock price target?
Price Target
5.688
EUR
According to Wall Street analysts, the average 1-year price target for 24H is 5.688 EUR with a low forecast of 2.769 EUR and a high forecast of 8.237 EUR.
What is the Revenue forecast for Hansa Biopharma AB?
Projected CAGR
50%
Over the last 13 years, the compound annual growth rate for Revenue has been 41%. The projected CAGR for the next 8 years is 50%.
What is the Gross Profit forecast for Hansa Biopharma AB?
Projected CAGR
88%
The compound annual growth rate for Gross Profit over the next 3 years is 88%.
